These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 11233800

  • 1. Impact of gemifloxacin on the normal human intestinal microflora.
    Barker PJ, Sheehan R, Teillol-Foo M, Palmgren AC, Nord CE.
    J Chemother; 2001 Feb; 13(1):47-51. PubMed ID: 11233800
    [Abstract] [Full Text] [Related]

  • 2. Ecological effect of gatifloxacin on the normal human intestinal microflora.
    Edlund C, Nord CE.
    J Chemother; 1999 Feb; 11(1):50-3. PubMed ID: 10078781
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparative in vitro potency of gemifloxacin and fluoroquinolones against recent European clinical isolates from a global surveillance study.
    Hoban DJ, Bouchillon SK, Johnson JL, Zhanel GG, Butler DL, Miller LA, Poupard JA, Gemifloxacin Surveillance Study Research Group.
    Eur J Clin Microbiol Infect Dis; 2001 Nov; 20(11):814-9. PubMed ID: 11783700
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evaluation of in vitro susceptibility testing criteria for gemifloxacin when tested against Haemophilus influenzae strains with reduced susceptibility to ciprofloxacin and ofloxacin.
    Biedenbach DJ, Jones RN.
    Diagn Microbiol Infect Dis; 2002 Aug; 43(4):323-6. PubMed ID: 12151195
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparative effects of levofloxacin and ofloxacin on the normal oral and intestinal microflora.
    Edlund C, Sjöstedt S, Nord CE.
    Scand J Infect Dis; 1997 Aug; 29(4):383-6. PubMed ID: 9360254
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A new respiratory fluoroquinolone, oral gemifloxacin: a safety profile in context.
    Ball P, Mandell L, Patou G, Dankner W, Tillotson G.
    Int J Antimicrob Agents; 2004 May; 23(5):421-9. PubMed ID: 15120718
    [Abstract] [Full Text] [Related]

  • 18. Gemifloxacin: a new fluoroquinolone approved for treatment of respiratory infections.
    Yoo BK, Triller DM, Yong CS, Lodise TP.
    Ann Pharmacother; 2004 May; 38(7-8):1226-35. PubMed ID: 15187209
    [Abstract] [Full Text] [Related]

  • 19. In vivo activity of gemifloxacin, moxifloxacin and levofloxacin against pneumococci with gyrA and parC point mutations in a sepsis mouse model measured with the all or nothing mortality end-point.
    Alkorta M, Giménez MJ, Vicente D, Aguilar L, Pérez-Trallero E.
    Int J Antimicrob Agents; 2005 Feb; 25(2):163-7. PubMed ID: 15664487
    [Abstract] [Full Text] [Related]

  • 20. Comparative efficacy of gemifloxacin in experimental models of pyelonephritis and wound infection.
    Berry V, Page R, Satterfield J, Singley C, Straub R, Woodnutt G.
    J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():87-93. PubMed ID: 10824038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.